New filter on dialysis machines could scratch itch and fatigue for kidney patients

NCT ID NCT07522008

Recruiting now Symptom relief Sponsor: Azienda Ospedaliera Brotzu Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether adding a blood-filtering step called hemoadsorption to regular dialysis can help people with kidney failure who still have bothersome symptoms like itching, tiredness, and trouble sleeping. Researchers will follow 120 adults for 6 months, tracking how their symptoms and quality of life change. It is an observational registry, meaning doctors use the filter as part of normal care, and the study just watches what happens.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hemoadsorption (a blood-filtering device added to standard dialysis)
What this could lead to: If successful, this could show that adding hemoadsorption to dialysis helps reduce stubborn symptoms like itching and fatigue, improving quality of life for kidney patients.
What could go wrong: This is an observational registry, not a controlled trial, so results may be influenced by other factors. It is small (120 people) and early, so it cannot prove the treatment works definitively.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE 5D are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bronchiolitis Obliterans Syndrome end stage renal failure uremia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE 5D UREMIA; CHRONIC

Contacts and locations

Locations

S.C.D.U. Nefrologia, Dialisi e Trapianto ARNAS G.Brotzu, Cagliari
RECRUITING

Cagliari, Italy, 09100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.